Full text is available at the source.
Inhalable Metal–Organic Frameworks: A Promising Delivery Platform for Pulmonary Diseases Treatment
Breathable Metal-Organic Frameworks as a New Way to Deliver Medicines for Lung Diseases
AI simplified
Abstract
Metal-organic frameworks (MOFs) may improve drug delivery efficiency to the lungs for treating respiratory diseases.
- Inhalation delivery enables direct administration of drugs to the lungs but struggles with maintaining effective concentrations over time.
- MOFs possess customizable porous structures and high surface areas, which could enhance drug retention and release in the lungs.
- The integration of MOFs into inhalation therapy may address challenges faced by traditional delivery methods.
- Recent advancements in the use of MOFs for inhalable drug formulations show potential in improving treatment outcomes for lung diseases.
- Future prospects may include translating the use of inhalable MOFs into clinical applications for respiratory disease management.
AI simplified